4-pyridinonetriazine derivatives as HIV integrase inhibitors
The present invention relates to 4-Pyridinonetriazine Derivatives of Formula (I); and pharmaceutically acceptable salts thereof, wherein A, X, Y, R1, R2, R3 and R5 are as defined herein. The present invention also relates to compositions comprising at least one 4-Pyridinonetriazine Derivative, and methods of using the 4-Pyridinonetriazine Derivatives for treating or preventing HIV infection in a subject.
Merck Sharp & Dohme Corp.
C C C A A A C C C C C A A
C07D C07D C07D A61K A61K A61K C07F C07D C07D C07D C07D A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Paul J. John Thomas Wensheng Thomas H. Yonglian Abbas Mark W. Tao Christina Sherman T.
Coleman Wai Steele Liu Graham Zhang Walji Embrey Yu Di Marco Waddell